FBG ELISA Kits (Fibrinogen ELISA Kits) are specialized enzyme-linked immunosorbent assay kits designed to detect and quantify fibrinogen levels in biological samples. Fibrinogen is a crucial plasma protein involved in blood clot formation and is an important biomarker for assessing coagulation status, inflammation, and cardiovascular risk.
Key Features of FBG ELISA Kits
- High Sensitivity and Specificity:
- Objective: Detect low concentrations of fibrinogen with high accuracy.
- Mechanism: Utilize high-affinity antibodies specifically targeting fibrinogen to ensure precise measurement with minimal cross-reactivity.
- Quantitative Measurement:
- Objective: Provide accurate quantification of fibrinogen levels in samples.
- Mechanism: Generate standard curves from known concentrations of fibrinogen to measure its levels in test samples.
- Optimized Protocols:
- Procedure: Includes coating, blocking, sample incubation, detection, and measurement steps optimized for reliable and reproducible results.
- Time Efficiency: Designed to deliver results within a few hours, depending on the specific kit and protocol used.
- Reagent Composition:
- Capture Antibody: Specific for fibrinogen, immobilized on the microtiter plate.
- Detection Antibody: Conjugated to an enzyme (e.g., horseradish peroxidase or alkaline phosphatase) that binds to fibrinogen and produces a detectable signal.
- Substrate Solution: Reacts with the enzyme to produce a measurable signal (colorimetric, fluorometric, or luminescent).
- Standard Curve Generation:
- Objective: Calibrate the assay for accurate quantification.
- Mechanism: Include fibrinogen standards in the assay to create a standard curve for determining the concentration of fibrinogen in the samples.
- Sample Types:
- Applicability: Suitable for various sample types, including serum, plasma, and other body fluids, depending on the kit specifications.
Applications
- Coagulation Disorders: Assess fibrinogen levels to diagnose and monitor disorders related to abnormal blood clotting, such as hemophilia and disseminated intravascular coagulation (DIC).
- Inflammation and Infection: Monitor fibrinogen levels as an inflammatory marker in conditions such as rheumatoid arthritis and sepsis.
- Cardiovascular Risk Assessment: Evaluate fibrinogen levels as a risk factor for cardiovascular diseases, including stroke and myocardial infarction.
- Surgical and Trauma Monitoring: Measure fibrinogen levels to manage bleeding risk and guide treatment during and after surgery or trauma.
- Research: Study fibrinogen dynamics in various biological and pathological processes.
|
|
|
|
|
|
|
|
|
|
|
|
|